Jump to Navigation | Jump to Content
American Bar Association

News & Developments »

New Jersey Law Precludes Punitive Damages in Aredia/Zometa Cases

The U.S. District Court for the Southern District of Ohio recently held that New Jersey law bars punitive damages for prescription pharmaceuticals that are approved by the FDA.


SCOTUS Invites Solicitor General's Comments on FSIA Decision

The U.S. Supreme Court invited the U.S. solicitor general's comments on petition to review a Ninth Circuit decision expanding jurisdiction under the Foreign Sovereign Immunities Act.


Fifth Circuit Addresses FDA Preemption of State-Law Claims

The court recently addressed the ever-present question of FDA preemption of state-law pharmaceutical claims, specifically those arising under Texas law.


Articles »

Rule 45 and You: The Young Lawyers' Guide to Federal Subpoenas

By David L. Schwan

The revised rule clears up much confusion.


What's New? Treatment of NTSB Reports and Underlying Findings

By Timothy S. Tomasik and Patrick J. Giese

Addressing the admissibility of government reports under Federal Rule of Evidence 803(8)(A)(iii) in the context of aviation litigation.


Decisions Limiting Toxic-Tort Claims: Aberration or Potential Trend?

By Andrew J. Scholz

New York stands out as one of the most difficult jurisdictions for defendants and their insurers.


Sound Advice »

audio Overview of U.S. Trade Sanctions

By Douglas Maag

Veteran litigator Douglas Maag details how U.S. economic and trade sanctions can affect the handling of mass-tort claims. (8:13 min)



Roundtables »

audio Hey, CAFA, Is That a Class Action: Mississippi Ex Rel Hood v. Au Optronics

Examining the holding in this newly announced decision and what it may mean for future parens patriae actions and other types of quasi-class actions or mass actions. (56:12)


audio The Future of Hydraulic Fracturing

Featuring a unique group of lawyers and non-lawyers to provide a fact-based peek into the future, including presentations and an interactive discussion among the panelists. (1:01:42)


audio Mutual Pharmaceutical Company, Inc. v. Bartlett and Preemption in Pharmaceutical Litigation

Learn about the significance of the Barltett decision and its impact on the Supreme Court's preemption holdings. (57:33)


Announcements »

Mass Torts: Spring 2014 Newsletter

The latest edition of Mass Torts is now available.


 
Mass Torts Leadership
Cochairs Web Editor Newsletter Editor

Eric Hudson

Memphis, TN


Deborah Elsasser

New York, NY


Vice Chair

Laurie Novion

Kansas City, MO

David Schwan

Houston, TX


Social-Media Editor

Courtney E. Ward-Reichard

Minneapolis, MN

James M. Beck

Philadelphia, PA


Leadership Development & Young Lawyer Outreach Liaison

Catherine Riegle Finley

Sun Valley, CA